Cellular and serological markers of disease activity in Indian patients with HIV/AIDSSEHGAL, S; DATTA, U; MUJTABA, S et al.Methods in cell science. 2002, Vol 24, Num 1-3, pp 107-114, issn 1381-5741, 8 p.Article

The surrogate marker and its discontents : pluralism in immunity maintenance among HIV-infected persons in TaiwanLEW-TING, Chih-Yin; CHEN, Li-Hsin.Sociology of health & illness (Print). 2008, Vol 30, Num 7, pp 1039-1054, issn 0141-9889, 16 p.Article

Risk factor criteriaSTAMPFER, Meir J; RIDKER, Paul M; DZAU, Victor J et al.Circulation (New York, N.Y.). 2004, Vol 109, Num 25, pp 3-5, issn 0009-7322, 3 p., SUPArticle

Principles of use of surrogate markers and endpointsKLUFT, C.Maturitas (Amsterdam). 2004, Vol 47, Num 4, pp 293-298, issn 0378-5122, 6 p.Conference Paper

Surrogate measures of insulin sensitivity vs the hyperinsulinaemic―euglycaemic clamp: a meta-analysisOTTEN, Julia; AHREN, Bo; OLSSON, Tommy et al.Diabetologia (Berlin). 2014, Vol 57, Num 9, pp 1781-1788, issn 0012-186X, 8 p.Article

Early change in proteinuria as a surrogate outcome in kidney disease progression: a systematic review of previous analyses and creation of a patient-level pooled datasetSTOYCHEFF, Nicholas; PANDYA, Kruti; OKPARAVERO, Aghogho et al.Nephrology, dialysis, transplantation (Print). 2011, Vol 26, Num 3, pp 848-857, issn 0931-0509, 10 p.Article

Immune markers measured before treatment predict outcome of intensive phase tuberculosis therapyBRAHMBHATT, S; BLACK, G. F; CARROLL, N. M et al.Clinical and experimental immunology (Print). 2006, Vol 146, Num 2, pp 243-252, issn 0009-9104, 10 p.Article

The specific role of isoflavones in reducing prostate cancer riskKUMAR, Nagi B; CANTOR, Alan; ALLEN, Kathy et al.The Prostate. 2004, Vol 59, Num 2, pp 141-147, issn 0270-4137, 7 p.Article

Clinical trials: Are these your patients?STORMS, William.Journal of allergy and clinical immunology. 2003, Vol 112, Num 5, pp S107-S111, issn 0091-6749, SUPConference Paper

Electrophysiological markers and predictors of the disease course in primary progressive multiple sclerosisSCHLAEGER, Regina; D'SOUZA, Marcus; SCHINDLER, Christian et al.Multiple sclerosis. 2014, Vol 20, Num 1, pp 51-56, issn 1352-4585, 6 p.Article

Surrogate markers and survival in women receiving first-line combination anthracycline chemotherapy for advanced breast cancerHACKSHAW, A; KNIGHT, A; BARRETT-LEE, P et al.British journal of cancer. 2005, Vol 93, Num 11, pp 1215-1221, issn 0007-0920, 7 p.Article

Considerations regarding efficacy endpoints in HIV vaccine trials : Executive summary and recommendations of an expert consultation jointly organized by WHO, UNAIDS and ANRS in support of the Global HIV Vaccine EnterpriseFRUTH, Uli.Vaccine. 2009, Vol 27, Num 14, pp 1989-1996, issn 0264-410X, 8 p.Article

Exceeding the limits of liver histology markersMEHTA, Shruti H; LAU, Bryan; AFDHAL, Nezam H et al.Journal of hepatology. 2009, Vol 50, Num 1, pp 36-41, issn 0168-8278, 6 p.Article

Eclipta alba extract with potential for hair growth promoting activityDATTA, Kakali; SINGH, Anu T; MUKHERJEE, Ashok et al.Journal of ethnopharmacology. 2009, Vol 124, Num 3, pp 450-456, issn 0378-8741, 7 p.Article

Plasma S100β and NSE levels and progression in multiple sclerosisKOCH, Marcus; MOSTERT, Jop; HEERSEMA, Dorothea et al.Journal of the neurological sciences. 2007, Vol 252, Num 2, pp 154-158, issn 0022-510X, 5 p.Article

Analysis of surrogate markers for target-specific therapy in breast carcinomas using archival materialsSASANO, Hironobu; SUZUKI, Takashi; MORIYA, Takuya et al.Biomedicine & pharmacotherapy. 2007, Vol 61, Num 9, pp 543-547, issn 0753-3322, 5 p.Conference Paper

Biomarker Development in Psoriatic ArthritisRITCHLIN, Christopher.Journal of rheumatology. 2012, Vol 39, pp 57-60, issn 0315-162X, 4 p., SUP89Conference Paper

Expression of cell-surface antigens in acute promyelocytic leukaemiaPAIETTA, Elisabeth.Baillière's best practice & research. Clinical haematology. 2003, Vol 16, Num 3, pp 369-385, issn 1521-6926, 17 p.Article

Proteomic analysis of BRCA1-depleted cell line reveals a putative role for replication protein A2 up-regulation in BRCA1 breast tumor developmentBOULEY, Julien; PIONNEAU, Cédric; VARINOT, Justine et al.Proteomics. Clinical applications (Print). 2010, Vol 4, Num 5, pp 489-498, issn 1862-8346, 10 p.Article

S100B as an additional prognostic marker in subarachnoid aneurysmal hemorrhageSANCHEZ-PENA, Paola; PEREIRA, Ana-Rosa; SOUROUR, Nader-Antoine et al.Critical care medicine. 2008, Vol 36, Num 8, pp 2267-2273, issn 0090-3493, 7 p.Article

Exercise affects the gene expression profiles of human white blood cellsFEHRENHACH, Elvira; BÜTTNER, Petra; MOSIG, Sandy et al.Journal of applied physiology (1985). 2007, Vol 102, Num 1, issn 8750-7587, 7-8,26-36 [13 p.]Article

Measurement of arterial wall thickness as a surrogate marker for atherosclerosisDE GROOT, Eric; KEES HOVINGH, G; WIEGMAN, Albert et al.Circulation (New York, N.Y.). 2004, Vol 109, Num 23, pp III.33-III.38, issn 0009-7322, SUPArticle

Statistical analysis, trial design and duration in Alzheimer's disease clinical trials: a reviewTHOMPSON, P. A; WRIGHT, D. E; COUNSELL, C. E et al.International psychogeriatrics. 2012, Vol 24, Num 5, pp 689-697, issn 1041-6102, 9 p.Article

Predictive value of reactive hyperemia for cardiovascular events in patients with peripheral arterial disease undergoing vascular surgeryHUANG, Alex L; SILVER, Annemarie E; GIBBONS, Gary et al.Arteriosclerosis, thrombosis, and vascular biology. 2007, Vol 27, Num 10, pp 2113-2119, issn 1079-5642, 7 p.Article

Surrogate Markers of Cardiovascular Disease in CKD: What's Under the Hood?RUBIN, Mario F; ROSAS, Sylvia E; CHIRINOS, Julio A et al.American journal of kidney diseases. 2011, Vol 57, Num 3, pp 488-497, issn 0272-6386, 10 p.Article